TLR-mediated cell signaling by malaria GPIs

D Channe Gowda1

  • 1Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. gowda@psu.edu

Trends in Parasitology
|November 6, 2007
PubMed

Insights

Malaria

Area of Science:

  • Immunology
  • Parasitology
  • Cellular Signaling

Background:

  • Proinflammatory responses are key in controlling malaria parasite growth and pathogenesis.
  • Plasmodium falciparum glycosylphosphatidylinositol (GPI) is implicated in inducing these responses.
  • Host cellular responses are primarily mediated by Toll-like receptor (TLR)2/MyD88 signaling.

Purpose of the Study:

  • To elucidate the cell-signaling mechanisms.
  • To understand malaria GPI-mediated innate immune activation and regulation.
  • To identify potential therapeutic or vaccine targets.

Main Methods:

  • Focus on malaria GPI-mediated cell-signaling pathways.
  • Analysis of parasite-host interactions in innate immunity.
  • Exploration of TLR2/MyD88 signaling cascades.

Main Results:

  • Malaria GPI is a critical activator of proinflammatory responses.
  • TLR2/MyD88 signaling is central to GPI-induced host cell activation.
  • Understanding these pathways offers insights into immune modulation.

Conclusions:

  • Malaria GPI-mediated signaling is a crucial aspect of host-parasite interaction.
  • Targeting GPI-induced signaling pathways may lead to novel malaria therapeutics or vaccines.
  • Further research into these mechanisms can advance malaria control strategies.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...